These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18469839)

  • 1. The metabolic syndrome and cardiovascular risk in the British Regional Heart Study.
    Wannamethee SG
    Int J Obes (Lond); 2008 May; 32 Suppl 2():S25-9. PubMed ID: 18469839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus.
    Wannamethee SG; Shaper AG; Lennon L; Morris RW
    Arch Intern Med; 2005 Dec 12-26; 165(22):2644-50. PubMed ID: 16344423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome as a predictor of cardiovascular diseases and type 2 diabetes in Koreans.
    Hwang YC; Jee JH; Oh EY; Choi YH; Lee MS; Kim KW; Lee MK
    Int J Cardiol; 2009 May; 134(3):313-21. PubMed ID: 19131127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes.
    Lorenzo C; Williams K; Hunt KJ; Haffner SM
    Diabetes Care; 2007 Jan; 30(1):8-13. PubMed ID: 17192325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.
    Meigs JB; Rutter MK; Sullivan LM; Fox CS; D'Agostino RB; Wilson PW
    Diabetes Care; 2007 May; 30(5):1219-25. PubMed ID: 17259468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of gamma-glutamyltransferase in cardiovascular risk prediction in men without diagnosed cardiovascular disease or diabetes.
    Wannamethee SG; Lennon L; Shaper AG
    Atherosclerosis; 2008 Nov; 201(1):168-75. PubMed ID: 18378241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overweight and obesity and weight change in middle aged men: impact on cardiovascular disease and diabetes.
    Wannamethee SG; Shaper AG; Walker M
    J Epidemiol Community Health; 2005 Feb; 59(2):134-9. PubMed ID: 15650145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular disease incidence and mortality in older men with diabetes and in men with coronary heart disease.
    Wannamethee SG; Shaper AG; Lennon L
    Heart; 2004 Dec; 90(12):1398-403. PubMed ID: 15547012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk prediction in a population with the metabolic syndrome: Framingham vs. UKPDS algorithms.
    Zomer E; Liew D; Owen A; Magliano DJ; Ademi Z; Reid CM
    Eur J Prev Cardiol; 2014 Mar; 21(3):384-90. PubMed ID: 22588087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does diagnosis of the metabolic syndrome detect further men at high risk of cardiovascular death beyond those identified by a conventional cardiovascular risk score? The DECODE Study.
    DECODE Study Group
    Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):192-9. PubMed ID: 17446796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
    Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR
    Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.
    Tong PC; Kong AP; So WY; Yang X; Ho CS; Ma RC; Ozaki R; Chow CC; Lam CW; Chan JC; Cockram CS
    Diabetes Care; 2007 May; 30(5):1206-11. PubMed ID: 17259472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome.
    Liu J; Grundy SM; Wang W; Smith SC; Vega GL; Wu Z; Zeng Z; Wang W; Zhao D
    Am Heart J; 2007 Apr; 153(4):552-8. PubMed ID: 17383293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients.
    Vlek AL; van der Graaf Y; Spiering W; Visseren FL;
    J Hum Hypertens; 2008 May; 22(5):358-65. PubMed ID: 18273039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes.
    Guzder RN; Gatling W; Mullee MA; Byrne CD
    Diabetologia; 2006 Jan; 49(1):49-55. PubMed ID: 16341841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic interactions between cardiovascular risk factors.
    Vishram JK
    Dan Med J; 2014 Jul; 61(7):B4892. PubMed ID: 25123126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Males aging with a spinal cord injury: prevalence of cardiovascular and metabolic conditions.
    LaVela SL; Evans CT; Prohaska TR; Miskevics S; Ganesh SP; Weaver FM
    Arch Phys Med Rehabil; 2012 Jan; 93(1):90-5. PubMed ID: 22200386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke: the Framingham Offspring Study.
    Najarian RM; Sullivan LM; Kannel WB; Wilson PW; D'Agostino RB; Wolf PA
    Arch Intern Med; 2006 Jan; 166(1):106-11. PubMed ID: 16401818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of adiponectin with metabolic and vascular risk parameters in the British Regional Heart Study reveal stronger links to insulin resistance-related than to coronory heart disease risk-related parameters.
    Wannamethee SG; Tchernova J; Whincup P; Lowe GD; Rumley A; Brown K; Cherry L; Sattar N
    Int J Obes (Lond); 2007 Jul; 31(7):1089-98. PubMed ID: 17264850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of cardiovascular disease and risk factors in a type 2 diabetic population of the North Catalonia diabetes study.
    Jurado J; Ybarra J; Solanas P; Caula J; Gich I; Pou JM; Romeo JH
    J Am Acad Nurse Pract; 2009 Mar; 21(3):140-8. PubMed ID: 19302689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.